Los Angeles Capital Management’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7K Sell
2,989
-44,993
-94% -$403K ﹤0.01% 1631
2025
Q4
$352K Sell
47,982
-13,182
-22% -$94.1K ﹤0.01% 1026
2025
Q3
$319K Sell
61,164
-7,451
-11% -$28.4K ﹤0.01% 1097
2025
Q2
$237K Buy
68,615
+3,275
+5% +$9.74K ﹤0.01% 1129
2025
Q1
$171K Buy
65,340
+12,570
+24% +$49.3K ﹤0.01% 1043
2024
Q4
$217K Buy
52,770
+20,880
+65% +$114K ﹤0.01% 1035
2024
Q3
$226K Sell
31,890
-74,279
-70% -$555K ﹤0.01% 1092
2024
Q2
$692K Buy
106,169
+92,230
+662% +$630K ﹤0.01% 769
2024
Q1
$116K Buy
13,939
+2,850
+26% +$27.8K ﹤0.01% 1118
2023
Q4
$122K Hold
11,089
﹤0.01% 1111
2023
Q3
$93.3K Buy
11,089
+175
+2% +$1.88K ﹤0.01% 1093
2023
Q2
$137K Buy
+10,914
New +$136K ﹤0.01% 1134
2022
Q4
Sell
-10,604
Closed -$237K 1266
2022
Q3
$237K Buy
+10,604
New +$233K ﹤0.01% 1143

Other funds holding RLAY